Complex I drives glutamine-dependent TCA cycle to support viability of MYChigh breast cancer cells
Open Access
- 3 July 2026
- journal article
- Published by Elsevier in Cell Reports
- Vol. 45 (7) , 117629
Abstract
No abstract availableKeywords
Funding Information
- Helsingin Yliopisto
This publication has 87 references indexed in Scilit:
- MYC and therapy resistance in cancer: risks and opportunitiesMolecular Oncology, 2022
- Targeting mitochondrial respiration and the BCL2 family in high‐grade MYC‐associated B‐cell lymphomaMolecular Oncology, 2021
- Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of OXPHOS Dependency in Acute Myeloid LeukemiaCancer Cell, 2019
- NAD + metabolism: Bioenergetics, signaling and manipulation for therapyBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2016
- PCR Based Determination of Mitochondrial DNA Copy Number in Multiple Species2014
- BAY 87‐2243, a highly potent and selective inhibitor of hypoxia‐induced gene activation has antitumor activities by inhibition of mitochondrial complex ICancer Medicine, 2013
- PGC1α Expression Defines a Subset of Human Melanoma Tumors with Increased Mitochondrial Capacity and Resistance to Oxidative StressCancer Cell, 2013
- Metabolic Signatures Uncover Distinct Targets in Molecular Subsets of Diffuse Large B Cell LymphomaCancer Cell, 2012
- qPCR-based mitochondrial DNA quantification: Influence of template DNA fragmentation on accuracyBiochemical and Biophysical Research Communications, 2012
- Induction of apoptosis in fibroblasts by c-myc proteinCell, 1992